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Abstract:  This case of Hansen's disease reminds 
clinicians of all ages and era that leprosy is not a 
disease of the past as such a systematized 
multidisplinary approach and timely referral to 
specialists should be followed when evaluating any 
patient with chronic dermatoses of unknown cause. 
Early diagnosis of leprosy coupled with prompt 
treatment with Multi Drug Therapy (MDT) are the 
most important steps in preventing permanent 
debilitating deformity and disability.
INTRODUCTION
Hansen's disease which is Leprosy is defined as a 
chronic granulomatous disease caused by the acid 
fastidious bacillus called Mycobacterium leprae that 
primarily affects the peripheral nervous system and 
1the skin.  Although it does affect other body parts as 
well like the reticulo-endothelial system (spleen, 
lymph nodes), musculoskeletal system, mucous 
membranes, eyes, testes, adrenals and other 
2systems.
In 1998, WHO categorically defined leprosy case, 
“as any person having one or more of the following 
features, and who has still to complete a full course 
of multiple drug treatment: hypopigmented or 
reddish skin lesion(s) with definite loss of sensation 
in those areas; involvement of the peripheral nerves, 
as evidenced by definite thickening with loss of 
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sensation (varying degrees); and skin-smear 
3positive for acid-fast bacilli''.
The current case notification of Leprosy in Zambia 
is at about 0.43 per 10,000 populations as recorded 
4by Kapata et al,.  However, as of year 2000, the 
prevalence rates had decreased to 0.67 / 10 000 
population. The author also notes that the Zambian 
scenario has a lot of inadequate data recording, poor 
surveillance systems, record keeping, and 
insufficient information on disaggregation by 
4geographical origin or gender.
Historically, in 1873, a Norwegian doctor called 
Gerhard Armauer Hansen first discovered 
Mycobacterium leprae while working in a 
leprosarium in Bergen, Norway. At that time in 
Europe, this region had the highest prevalence of 
 leprosy. However, the scourge of leprosy appeared 
to have peaked in the Middle Ages as the disease 
spread through Europe as scribed by the ancient 
Greek, Roman and Egyptian writings. Hansen's 
disease was generally thought to be a heritable 
disease before the era of modern and current 
5microbiology was developed.
Clinically this neglected tropical infectious 
condition has a variable clinical presentation in 
reference to the patient's immune status. The Ridley 
and Jopling /WHO classification criteria, is based 
totally on; scientifically clinical symptoms, 
pathological, bacilloscopic, and immunological 
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components of the disorder, thus, allowing for a 
radical characterization or instead categorization of 
six leprosy class: the polar tuberculoid leprosy (TT), 
borderline tuberculoid (BT), the intermediate 
borderline-borderline (BB), borderline lepromatous 
6(BL) and lepromatous leprosy (LL) form.  A sixth 
form is the indeterminate leprosy (IL), which is also 
commonly used to refer to leprosy which may 
resolve or progress further to anyone of the five 
forms of leprosy within the Ridley-Jopling system.
Another simplified classification of leprosy based 
on the bacterial index (BI) classifies leprosy into two 
categories: paucibacillary (PB) and multibacillary 
(MB) which is helpful in operational and therapeutic 
purposes. In PB, the BI is lower than 2+ and in MB 
7the index higher than or equal to 2+.
The complications of leprosy can be both socially 
and emotionally debilitating both to the patient and 
the next of kin. In this case report we discuss and 
review a case of a 35-year-old female with 
physically debilitating Lepromatous leprosy.
Case Presentation: A 35-years-old single woman 
had presented to the out-patient department with a 
with a long-standing history of worsening macular-
papular rash with associated development of hyper 
and hypopigmented skin lesions for over two years. 
Since the first presentation, she was managed as a 
case of chronic dermatoses with infected skin ulcers 
under investigation and was covered on systemic 
short course of antibiotics and advised on daily 
wound care.
When we first saw the patient, she reported 
worsening skin lesions, coalescing of the macular 
papular rashes, hardening of the skin, facial changes 
disfigurement, worsening of skin ulcers especially 
on legs which where discharging chalky-watery 
fluid, malaise and occasional fevers since the past 
three years of being evaluated as an out-patient.
The review of other systems was unremarkable. The 
client was found to be HIV/AIDS sero-negative and 
had no significant medical nor surgical history. 
Her local skin exam revealed granulomatous, shiny 
coalesced nodular-papular lesions around the face 
and ears with associated skin ulceration. She had a 
saddle nose, loss of eye brows. The limbs had a 
mixture of both hyper and hypopigmented lesions 
with multiple ulcers on the upper and lower limbs 
which had clear margins, granulating clean surfaces 
with sero-purulent discharge on some lesions. There 
were areas of skin induration and woody hard on 
palpation as seen in figure 1 (A-E). She had normal 
morphology of fingers and toes. However, 
neurological exam could not be accessed due to 
woody hard nature of the limbs. Also peripheral 
nerve enlargement was not appreciated.
Figure: (A-C) Lepromatous leprosy: dysfiguration, infiltrated 
face with nodular-papular lesions, saddle nose and madarosis, 
granulomatous lesions on ear lobes with superficial ulcers on 
the cheeks.(D-E) complications of nerve damage evidenced as 
excoriations, multiple skin ulcers with hyper and 
hypopigmented lesions on limbs, however she had normal 
fingers and toes (F) Indicates positive (+++) mycobacterium 
leprae of over ten per High Power Field(>10AFB/1HPF) from 
the nose, both ears, hands and legs under Ziehl-Neelsen
Skin biopsy/ scrapping 'revealed' positive (+++) 
mycobacterium leprae of over 10 per High Power 
Field (>10AFB/1HPF) from the nose, both ears, 
hands and legs under Ziehl-Neelsen as shown in 
figure 1F. Other investigations were within the 
normal range as indicated in table 1.
The patient was managed as Lepromatous Leprosy 
based on the clinical picture and positive laboratory 
findings and was initiated on Multi Drug Therapy 
(MDT), as per protocol on: Clofazimine 300mg 
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once a day, Rifampicin 600mg once a day, and 
Dapsone 100mg once a day for a year with 
scheduled reviews. Also, the client was offered daily 
wound care, pyridoxine, multivitamins and vitamin 
B complex supplement.
Table 1: investigations done during period of 
admission
After eight weeks of the above constituted 
management, the patient had shown tremendous 
improvement and the ulcers had healed. However, 
for the woody hard and scared skin lesions, nothing 
more could be done. She was advised that she would 
have to bear with the 'mummified' kind of skin with 
the hope that it may soften with time. A social worker 
and psychologist where incorporated to address her 
psychosocial needs. 
DISCUSSION 
The mycobacterium leprae organism was declared 
less virulent and almost eradicated in most parts of 
the world with most sanatoriums converted to either 
health centers or hospitals for all kinds of conditions 
with the best example in Zambia being Liteta 
General Hospital in Chibombo district, Central 
province. Yet the organism has found means and 
ways to still cause devastating conditions to our 
client in this era in a sporadic pattern. Our client 
battled with symptoms of leprosy but they were 
dismissed due to the fact that the condition was 
considered controlled as per the World Health 
Organization (WHO) target of yearly overall 
prevalence rate of less than one case for every 
810,000 populations.
Most clinicians have never seen an active case of 
leprosy in this era, thus the patient was treated as 
unknown chronic dermatoses in the early days. This 
case-review reminds us that these infectious and 
ancient ailments should always be thought of despite 
the disease being considered as an eradicated disease 
especially in our part of the world. The earlier 
manifestations of leprosy in our client was 
completely missed due to either due to lack of 
specialist availability in the area of her origin or and 
largely due to knowledge gap amongst clinicians. 
There has not being any cases of leprosy in the 
region of her origin. Also, the health facilities that 
our client initially sort medical attention had no 
capacity to further investigate the clinical 
presentation of the patient thus, she was managed as 
a case of infected chronic dermatoses of unknown 
cause.
Clinically, Leprosy affects mostly the peripheral 
nervous system, the mucocutaneous system; the 
mucosa membranes of the upper respiratory 
9pathways are never spared.  It is essentially a disease 
of the poor with its transmission thought to be 
through nasal droplets as is the suspicion with our 
patient. Although she denied contact with any 
person with similar presentation. The point of 
contact with the organism in our patient was illusive 
and thus, earliest thoughts' of Hansen's disease was 
completely never  enter tained.  Zoonotic  
transmission has been recorded especially when in 
contact with armadillos as documented by Storrs 
E.E et al.,1974.  Prolonged skin contact with an 
untreated patient and direct inoculation are some 
10other mode of transmission.  However, the precise 
mode of transmission is still unclear but frequent, 
repeated, close contact with an untreated person for a 
Test
 
Value Normal range
Complete Blood count
  
WBC
 
4.10x 109/L 4.00 - 10.00
Neutrophils
 
2.21x109/L 0.96- 6.40
Lymphocytes
 
1.37x109/L 0.84 – 3.26
Monocytes
 
0.52 x109/L 0.08 – 0.61
RBC  3.99x 1012/L 4.13 – 5.67
Hemoglobin  10.2g/dL 12.1 – 16.3
HCT  34.7% 35.0 – 47.0
MCV  87.0fl 79.1 - 98.9
MCHC  29.4g/dL 32.0 – 36.0
Red cell distribution width  19.3% 11.6 -14.0
Platelets  443x 109/L 150 - 400
ESR  Nil
Biochemistry   
S-Urea  3.23mmol/L 2.80- 7.10
Creatinine  80.1µmol/L 45.0 – 84.0
Alanine Transaminase  20.6U/L 0.0 – 34.0
Aspartate Transaminase  29.6 IU/L 0.0 – 31.0
Others   
Syphilis RPR  Non-Reactive
Malaria  Negative Slide
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longer period of time can lead to contracting leprosy. 
The disease isn't highly contagious as compared to 
other mycobacterium species. 
In an attempt to explain the clinical presentation of 
our client, the development of symptoms is due to 
the immune status and cellular immune response of 
the client or host to M. leprae organism than on the 
bacillary penetration virulence and multiplication 
ability. Clinical presentations are almost always 
followed by a long incubation period, ranging 
between several months and twenty years with an 
average period of two to four years. Hence, if 
clinician has a low index of suspicion, may miss or 
11misdiagnose the disease.
The pathophysiological progress of Hansen's 
disease is thought to be a model of graded cell-
mediated immunity, with the trigger in this case to 
the causative organism, Mycobacterium leprae. The 
clinical presentations are as a result of constellation 
of serval factors: a) due to bacterial progression, b) 
immunologic responses of the host, c) peripheral 
nerve damage as a result of either or both bacterial 
progression and immunologic responses of the host, 
and d) Ultimately the preventable secondary 
deformities because of nerve damage, which 
basically account for most of the psychosocial 
9stigma of the disorder in leprosy patients.
The evolving clinical picture starts as innocent as 
small number of hypochromic spots or macules 
(light skin patches), with associated slight decrease 
in sensitivity to pain and light touch, without 
noticeable increase in nerve thickness to single skin 
lesions or a small number of asymmetric skin 
lesions. They are defined by erythematous plaques 
and nodules in some cases. Often the ulcers are with 
elevated external borders and hypochromic centers, 
also presenting with significant change in sensitivity 
of pain, light touch and pressure. Alopecia and 
anhidrosis are other features of leprosy as a result of 
denervation of the skin appendages, and thickening 
of the nearby nerve sheath, and hyperkeratosis and 
or ulceration in the compression areas. These 
aforementioned features were present in our client at 
the time diagnosis. The peripheral nerve damage in 
leprosy often results in severe sensory and motor 
dysfunctions that often lead to permanent 
12deformities and or disabilities.  The sensitive 
change within the nerve route, with or without any 
substantive nerve thickening, has been the only 
manifestation in some instances, characterizing the 
11primary neural form of the disease.
MDT treatment options are readily available to 
control or minimize the effects of bacterial 
progression, undesirable immunologic responses of 
the host, also peripheral nerve damage, and 
secondary deformities. Preventive measures have 
also been put in place from vaccination of neonates 
with Bacillus Calmette–Guérin (BCG) vaccines to 
treatment of contacts of leprosy cases with 
protracted course of rifampicin. However, isolation 
of leprosy cases is not required since the condition is 
13not highly infectious.
Untreated patients or late diagnosis almost always 
leads to irreversible or rather permanent disabilities 
and depressing disfiguring complications, like the 
leonine facies. These physical complications are 
associated with socio-cultural construction of 
leprosy are responsible for stigma and psychosocial 
14,15exclusion of leprosy victims.  
CONCLUSION
This case of leprosy reminds general practitioners 
that leprosy and other neglected tropical diseases are 
not ailments of the past and thus, a systemic and 
multidisplinary approach have to constantly be 
followed when in limbo. Early diagnosis of leprosy 
is a prerequisite for effective therapy and 
rehabilitation. Early detection and treatment by 
MDT are the most important steps in preventing and 
decreasing chances of severe deformity and 
disability. 
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